Effect of chromium picolinate on insulin sensitivity in vivo

Journal of Trace Elements in Experimental Medicine

Volumn 12, Issue 2, 1999, Pages 71-83

  Cefalu, William T ^a,b   Bell Farrow, Audrey D ^a   Stegner, Jane ^a   Wang, Zhong Q ^a   King, Telle ^a   Morgan, Tim ^a   Terry, James G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Chromium; Insulin resistance; Insulin sensitivity; Type 2 diabetes

Indexed keywords

CHROMIUM PICOLINATE; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ABDOMEN; ADULT; ANTHROPOMETRIC PARAMETERS; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032953710     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-670X(1999)12:2<71::AID-JTRA4>3.0.CO;2-8     Document Type: Conference Paper

References (40)

1. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37: 1595-1607.
2. Defronzo RA. Lilly Lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
3. American Diabetes Association: Clinical Practice Recommendations 1998: report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998;21(Suppl 1G2):S5-S19.
4. Mertz W. Chromium in human nutrition: a review. J Nutr 1993;123:626-633.
5. Anderson RA. Recent advances in the clinical and biochemical effects of chromium deficiency. Prog Clin Biol Res 1993;380:221-234.
6. Anderson RA, Polansky MM, Bryden NA, Canary JJ. Supplemental chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr 1991;54:909-916.
7. Anderson RA. Chromium, glucose tolerance and diabetes. Biol Trace Elem Res 1992;32:19-24.
8. Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 1989;11:163-180.
9. Evans GW. An inexpensive, convenient adjunct for the treatment of diabetes. West J Med 1991;155: 549.
10. Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, Elahi D. Glucose metabolism in glucose intolerant older people during chromium supplementation. Metab Clin Exp 1985;34:199-204.
11. Hasten DL, Rome EP, Franks BD, Hegsted M. Effects of chromium picolinate on beginning weight training students. Int J Sport Nutr 1992;2:343-350.
12. Page TG, Ward TL, Southern LL. Effect of chromium picolinate on growth and carcass characteristics of growing-finishing pigs. J Anim Sci 1991;71:656-662.
13. Boleman SL, Boleman SJ, Bidner TD, Southern LL, Ward TL, Pontif JE, Pike MM. Effect of chromium picolinate on growth, body composition, and tissue accretion in pigs. J Anim Sci 1995; 73:2033-2042.
14. Uusitupa MI, Mykkanen L, Siitonen O, Laakso M, Sarlund H. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr 1992;68:209-216.
15. Roeback JR Jr, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipo-protein cholesterol levels in men taking beta blockers. Ann Int Med 1991;12:917-924.
16. Elwood JC, Nash DT, Streeten DHP. Effect of high-chromium brewer's yeast on human serum lipids. J Am Coll Nutr 1982;1:263-268.
17. Anderson RA, Cheng N, Bryden NA. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997;46:1786-1791.
18. Glinsman WH, Mertz W. Effect of trivalent chromium on glucose tolerance. Metabolism 1966;15: 510-520.
19. Nath R, Minocha J, Lyall V, Sunder S, Kumar V, Kapoor S, Dhar KL. Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. In: Shapcott D, Hubert J, editors. Chromium in nutrition and metabolism. Amsterdam: Elsevier; 1979.
20. Feskens EJM, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. Am J Epidemiol 1989;130:1101-1108.
21. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S. Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med 1983;102:621-627.
22. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988;37:338-345.
23. Folsom AR, Burke GL, Ballew C, Jacobs DR, Haskell WL, Donahue RP, Liu KA, Hilner JE. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin. Am J Epidemiol 1989;130:911-924.
24. Kissebah AH, Peiris AN, Evans DJ. Mechanisms associating body fat distribution to glucose intolerance and diabetes mellitus: window with a view. Acta Med Scand 1988;723:79-89.
25. Thompson CJ, Ryu JE, Craven TE, Kahl FR, Crouse JR3d. Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb 1991;11:372-333.
26. Nutrition Data System. Nutrition Coordinating Center, University of Minnesota, Division of Epidemiology, Minneapolis, MN.
27. Cefalu WT, Wang, ZQ, Werbel S, Bell-Farrow AD, Crouse JR, Hinson WH, Terry JG, Anderson R. Contribution of visceral fat mass to the insulin resistance of aging. Metab Clin Exp 1995;44:954-959.
28. Cefalu WT, Werbel S, Bell-Farrow AD, Terry JG, Wang ZQ, Opara EC, Morgan T, Hinson WH, Crouse JR3d. Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular aging. Metab Clin Exp 1998;47:401-408.
29. Seidell JC, Bakker CJG, Van der Kooy K. Imaging techniques for measuring adipose tissue distribution - a comparison between computed tomography and 1.5 magnetic resonance. Am J Clin Nutr 1990;51:953-957.
30. Terry JG, Hinson WH, Evans GW, Schreiner PJ, Hagaman AP, Crouse JR3d. Evaluation of magnetic resonance imaging for quantification of intraabdominal fat in human beings by spin-echo and inversion-recovery protocols. Am J Clin Nutr 1995;62:297-301.
31. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetic Books; 1988.
32. Cefalu WT, Wang ZQ, Bell-Farrow A, Ralapati S. Liver and kidney tissue membranes as tissue markers for non-enzymatic glycation. Diabetes 1991;40:902-907.
33. Cefalu WT, Bell-Farrow AD, Petty M, Izlar C. Clinical validation of a new, 2nd generation fructosamine assay. Clin Chem 1991;37:1252-1256.
34. Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. J Am Med Assoc 1979;241:496-498.
35. Anderson RA. Chromium and parenteral nutrition. Nutrition 1995;11:83-86.
36. Recommended Dietary Allowances. 10th ed. Subcommittee on the Tenth Edition of the RDAs; Food and Nutrition Board, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press; 1989.
37. Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate. J Am Coll Nutr 1997;16:273-279.
38. Fujioka S, Matsuzawa Y, Tokunaga K, Tarvi S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987;36:54-59.
39. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann NY Acad Sci 1993;676:270-278.
40. Kaats GR, Blum K, Pullin D, Keith SC, Wood R. A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation of body composition: a replication and extension of a previous study. Curr Ther Res 1998;59:6.